Top Markets
#1 Black Phoenix Black Phoenix +825.47%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +24.88%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.87%
#4 Prom Prom +20.14%
#5 SAFEcoin SAFEcoin +19.78%
#6 Magma Finance Magma Finance +19.66%
#7 Beam Beam +19.21%
#8 Bless Bless +17.62%
#9 pipedog pipedog +17.24%
#10 YFSX YFSX +16.01%
Coin of the day
Black Phoenix Black Phoenix
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
China Resources Double-Crane Pharmaceutical Co.,Ltd. China Resources Double-Crane Pharmaceutical Co.,Ltd.

China Resources Double-Crane Pharmaceutical Co.,Ltd.

600062
Classificação em ações #5801
China Resources Double-Crane Pharmaceutical Co.,Ltd., together with its... China Resources Double-Crane Pharmaceutical Co.,Ltd., together with its affiliated companies, operates as a prominent pharmaceutical enterprise within the People's Republic of China. The company's diverse product range includes various types of infusion solutions, available in soft bags, plastic and glass bottles, as well as inner-sealed and blend polypropylene bags. Its manufacturing capabilities extend to numerous injectable products, such as levofloxacin methylate, ambroxol hydrochloride glucose, fructose, invert sugar, hydroxyethyl starch, and sodium chloride injections, among others. Additionally, it supplies vital dialysate solutions for both peritoneal and hemodialysis. A substantial part of its portfolio is dedicated to addressing cardiovascular and cerebrovascular diseases, featuring medications like compound reserpine triamterene tablets, pitavastatin calcium tablets, telmisartan capsules, suppository capsules, banidipine hydrochloric acid sustained-release capsules, and edaravone. Furthermore, China Resources Double-Crane offers treatments for endocrinological conditions and a selection of pediatric drugs, notably including pediatric compound amino acid injections. The company's offerings also encompass nutritional supplements, such as vitamins E and C, and a variety of anti-infective pharmaceuticals. Headquartered in Beijing, the People's Republic of China, China Resources Double-Crane Pharmaceutical Co.,Ltd. is an affiliate of Beijing Pharmaceutical Group Co., Ltd.
Preço da ação
$2.34
Valor de mercado
$2.43B
Variação (1 dia)
-0.37%
Variação (1 ano)
-14.62%
País
CN
Negociar China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062)

Categoria

Healthcare
Histórico de desdobramentos de ações de China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062)
As ações China Resources Double-Crane Pharmaceutical Co.,Ltd. (símbolo: 600062) passaram por um total de 0 desdobramentos.
O desdobramento mais recente ocorreu em Aug 27, 2026.
Uma ação 600062 comprada antes de Aug 27, 2026 equivaleria hoje a 0 ações 600062.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
Não há dados suficientes para as datas fornecidas.
Desdobramentos de ações de empresas semelhantes ou concorrentes
Empresa Número de desdobramentos de ações Multiplicador cumulativo País
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 0 -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 0 -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 0 -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 0 -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 5 x119
IN